A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer.

Clinical trial NCT06746688 · RECRUITING

Trial details

NCT number: NCT06746688
Sponsor: ExpreS2ion Biotechnologies
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Metastatic

Start date: 2025-06-03
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.